This site is intended for healthcare professionals. Not a healthcare professional? Visit Mill-Klinika
All 2006 2007 2008 2009 2010 2010-2011 2011 2012 2012 2013 2013 2014 2014 2015 2015 2016 2016 2017 2017 2018 2018 2019 2019 Articles Associates Associates - archive CME Collis Williams Contributions Contributors Corporate News Archive Dr Charles Savona-Ventura Dr Ian Ellul Dr Pierre Vassallo e-info Archive e-Learning Events Flame Series Francesco Carelli GSK Issue 1 - 2006 Issue 1 - 2007 Issue 1 - 2008 Issue 1 - 2009 Issue 1 - 2010 Issue 1 - 2011 Issue 1 - 2012 Issue 1 - 2013 Issue 1 - 2014 Issue 1 - 2015 Issue 1 - 2016 Issue 1 - 2017 Issue 1 - 2018 Issue 1 - 2019 Issue 1 - 2020 Issue 1 - 2021 Issue 1 - 2022 Issue 2 - 2006 Issue 2 - 2007 Issue 2 - 2008 Issue 2 - 2009 Issue 2 - 2010 Issue 2 - 2011 Issue 2 - 2012 Issue 2 - 2013 Issue 2 - 2014 Issue 2 - 2015 Issue 2 - 2016 Issue 2 - 2017 Issue 2 - 2018 Issue 2 - 2019 Issue 2 - 2020 Issue 2 - 2021 Issue 2 - 2022 Issue 3 - 2006 Issue 3 - 2007 Issue 3 - 2008 Issue 3 - 2009 Issue 3 - 2010 Issue 3 - 2011 Issue 3 - 2012 Issue 3 - 2013 Issue 3 - 2014 Issue 3 - 2015 Issue 3 - 2016 Issue 3 - 2017 Issue 3 - 2018 Issue 3 - 2019 Issue 3 - 2020 Issue 3 - 2021 Issue 4 - 2006 Issue 4 - 2007 Issue 4 - 2008 Issue 4 - 2009 Issue 4 - 2010 Issue 4 - 2011 Issue 4 - 2012 Issue 4 - 2013 Issue 4 - 2014 Issue 4 - 2015 Issue 4 - 2016 Issue 4 - 2017 Issue 4 - 2018 Issue 4 - 2019 Issue 4 - 2020 Issue 4 - 2021 Issue 5 - 2006 Issue 5 - 2007 Issue 5 - 2008 Issue 5 - 2010 Issue 5 - 2011 Issue 5 - 2012 Issue 5 - 2013 Issue 5 - 2014 Issue 5 - 2015 Issue 5 - 2016 Issue 5 - 2017 Issue 5 - 2018 Issue 5 - 2019 Issue 5 - 2020 Issue 5 - 2021 Issue 5 – 2009 Issue 6 - 2006 Issue 6 - 2007 Issue 6 - 2008 Issue 6 - 2009 Issue 6 - 2010 Issue 6 - 2011 Issue 6 - 2012 Issue 6 - 2013 Issue 6 - 2014 Issue 6 - 2015 Issue 6 - 2016 Issue 6 - 2017 Issue 6 - 2018 Issue 6 - 2019 Issue 6 - 2020 Jamesco Library Magazines Medical News Medical News Archived MMSA Network News Network News Archive News Novartis Novo Nordisk Partners Servier SMS4Health Sponsored Videos Technoline TheSynapse e-Learning TheSynapse Magazines TheSynapse Online TheSynapse Videos Uncategorised Uncategorized Vivian Webinars on Diabetes

New Tresiba® Summary of Product Characteristics: European Commission approves the label expansion to include children with type 1 and type 2 diabetes

by January 16, 2020

In December 2014 Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for expanded use of Tresiba® (insulin degludec) in children and adolescents aged 1-17 years with diabetes. And now, after the approval of the European…

Associates - archive, Corporate News Archive, Novo Nordisk, TheSynapse Online

Tresiba (Insulin Degludec): Flexibility in day-to-day dosing time when needed

by January 16, 2020

Poor glucose control in patients with diabetes can ultimately result in diabetic complications that can bedevastating for the patient’s quality of life, life-shortening, and expensive to treat for national healthcare systems.Current expert guidelines on the treatment of type 2 diabetes therefore advocate the addition of…

Associates - archive, Corporate News Archive, Novo Nordisk, TheSynapse Online